<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01318876</url>
  </required_header>
  <id_info>
    <org_study_id>pcirn-surveillancehcw-1011</org_study_id>
    <nct_id>NCT01318876</nct_id>
  </id_info>
  <brief_title>Surveillance for Adverse Events Following Influenza Immunization</brief_title>
  <official_title>Active Surveillance of Adverse Events Following Immunization Among Healthcare Workers Immunized With the Influenza Vaccine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>PHAC/CIHR Influenza Research Network</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut National en Santé Publique du Québec</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Laval University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CHU de Quebec-Universite Laval</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mount Sinai Hospital, Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>IWK Health Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre de recherche du Centre hospitalier universitaire de Sherbrooke</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Ottawa Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>PHAC/CIHR Influenza Research Network</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Influenza vaccines are continuously modified to adjust to the virus antigenic shifts or
      drifts, and its safety profile may vary. While generally considered safe, influenza vaccines
      have been associated in the past with increases in cases of Guillain-Barré syndrome (1976)
      and with oculorespiratory syndrome in 2001. Last year, with the vaccination against the
      pH1N1, an increase of allergic-like reactions was observed.

      Passive surveillance is collecting notifications of adverse events (AE) on the whole
      population but the sensitivity of this system is not high and its timeliness is not
      necessarily optimal. Last year, with the new pandemic Influenza vaccine the investigators
      piloted a web-based active surveillance of a large number of health care workers (HCW)
      vaccinated with the new adjuvanted monovalent pH1N1 influenza vaccine (Arepanrix® GSK,
      Canada). Because healthcare workers (HCW) constituted a well-defined group with general good
      health and received the Influenza vaccine in priority, this group of people was well suited
      for monitoring the safety of the influenza vaccine. For this study, 6242 HCW were recruited
      in three different sites (5183 were from Quebec). A total of 468 events (local reactions,
      fever, systemic reactions, gastrointestinal and respiratory problems) were reported by 430
      HCW. 80% of the HCW recruited completed at least one of the three surveys and 52% responded
      to all questionnaires. During this surveillance, the investigators didn't have unexpected
      findings but this active surveillance of adverse events among healthcare workers would have
      been effective enough to rapidly detect adverse events occurring at a rate ≥ 1 per 200
      vaccinees. For this year the investigators want to expand the surveillance to more sites and
      more participants to be able to detect AE occurring at rates ≥ 1 per 500 vaccinees, and to
      increase the response rate to all three surveys in participants.

      The main objective of this project is to estimate in HCW vaccinated against influenza the
      frequency of adverse events of sufficient severity to cause work absenteeism or medical
      consultation.

      This year the network will include 5 Canadian hospitals (Quebec City, Vancouver, Toronto,
      Halifax, + another one ) with a total enrollment of &gt;10 000 HCW. This should allow us to
      detect AE occurring at a rate of ≥ 1 per 500 vaccinees.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants Who Had Experienced a New Health Problem or the Worsening of an Existing Health Condition That Resulted in a Medical Consultation</measure>
    <time_frame>at day 8 and 29</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants Who Had Experienced a New Health Problem or the Worsening of an Existing Health Condition That Resulted in Work Absenteeism.</measure>
    <time_frame>day 8 and 29</time_frame>
  </primary_outcome>
  <number_of_groups>7</number_of_groups>
  <enrollment type="Actual">7645</enrollment>
  <condition>Influenza</condition>
  <condition>Vaccines Adverse Reaction</condition>
  <arm_group>
    <arm_group_label>BC Children's and Women's Hospital, Vancouver.</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>University of British Columbia, Vancouver.</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Health care workers in Halifax</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Health care workers from CHUQ hospitals</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Health care workers from Toronto</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Centre hospitalier et universitaire de Sherbrooke</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>The Ottawa General Hospital, Ottawa</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The active surveillance was conducted in five Canadian hospitals participating in the
        Public Health Agency of Canada/Canadian Institutes for Health Research-Influenza Research
        Network (PCIRN): Quebec City, Toronto, Halifax, Vancouver (2 sites), Ottawa and Sherbrooke.
        Healthcare workers immunized in these institutions were offered to participate in a
        web-based active surveillance of vaccine safety.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  To be a healthcare worker from one of the seven Canadian Hospitals participating in
             the Public Health Agency of Canada/Canadian Institutes for Health Research-Influenza
             Research Network (PCIRN): Quebec City, Toronto, Halifax, Vancouver, Ottawa and
             Sherbrooke.

          -  To have been immunized with the influenza vaccine 2010

          -  To have an email address

          -  To be 18 years old and older

          -  To have sign the consent form

        Exclusion Criteria:

          -  Pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>BC Children's and Women's Hospital, Vancouver</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of British Columbia,</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Canadian Center for Vaccinology, Halifax</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Ottawa General Hospital,</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Hospital, Toronto</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Québec</name>
      <address>
        <city>Québec</city>
        <state>Quebec</state>
        <zip>G1V 4V2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier et Universitaire de Sherbrooke</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2011</study_first_submitted>
  <study_first_submitted_qc>March 18, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 21, 2011</study_first_posted>
  <results_first_submitted>July 9, 2012</results_first_submitted>
  <results_first_submitted_qc>July 9, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 14, 2012</results_first_posted>
  <last_update_submitted>August 15, 2012</last_update_submitted>
  <last_update_submitted_qc>August 15, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 21, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>PHAC/CIHR Influenza Research Network</investigator_affiliation>
    <investigator_full_name>Gaston De Serres</investigator_full_name>
    <investigator_title>Epidemiologist at the National Institute of Public Health of Quebec and professor of epidemiology at the University Laval</investigator_title>
  </responsible_party>
  <keyword>influenza</keyword>
  <keyword>vaccine safety</keyword>
  <keyword>adverse events</keyword>
  <keyword>health care workers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Influenza, Human</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Health Care Workers</title>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Day 8 Survey</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="7645"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5825"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1820"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>email address invalid</title>
              <participants_list>
                <participants group_id="P1" count="96"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>survey not completed-don't know why</title>
              <participants_list>
                <participants group_id="P1" count="1724"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Day 29 Survey</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="7549">All participants with a valid e-mail, have received the second survey</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5724"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1825"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>survey not completed-don't know why</title>
              <participants_list>
                <participants group_id="P1" count="1825"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Health Care Workers</title>
          <description>HCW who had completed at least 1 survey (n=6269) and not the number of participants enrolled in the study.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="6269"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="NA">participants under 18 years old were not recruted.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6269"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41.77" spread="11.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4639"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1630"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Who Had Experienced a New Health Problem or the Worsening of an Existing Health Condition That Resulted in a Medical Consultation</title>
        <time_frame>at day 8 and 29</time_frame>
        <group_list>
          <group group_id="O1">
            <title>HCW From All Sites</title>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Had Experienced a New Health Problem or the Worsening of an Existing Health Condition That Resulted in a Medical Consultation</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6269"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="153"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Who Had Experienced a New Health Problem or the Worsening of an Existing Health Condition That Resulted in Work Absenteeism.</title>
        <time_frame>day 8 and 29</time_frame>
        <group_list>
          <group group_id="O1">
            <title>HCW From All Sites</title>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Had Experienced a New Health Problem or the Worsening of an Existing Health Condition That Resulted in Work Absenteeism.</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6269"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="254"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>HCW From All Sites</title>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="6269"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>anaphylactic shock to peanuts</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6269"/>
              </event>
              <event>
                <sub_title>allergic reaction (received epinephrine)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6269"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>kidney stone</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6269"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>uterine fibroids</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6269"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>bilateral pulmonary embolism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6269"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Spontaneous intracranial hypotension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6269"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>3</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6269"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Only 70% answered the 2 surveys. We don't know why 30% didn't complete the 2 surveys (were they too sick or not motivated).We didn't have a group of comparable unvaccinated individuals (to estimate the risks attributable to the vaccine).</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Gaston De Serres</name_or_title>
      <organization>Laval University</organization>
      <phone>418-666-7000 ext 274</phone>
      <email>gaston.deserres@ssss.gouv.qc.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

